#Latest news with #internationalstudiesBloomberg11 hours agoHealthBloombergGilead's Twice-a-Year HIV Prevention Shot Wins FDA ApprovalBy Updated on Save Gilead Sciences Inc. said it won US approval for a drug to prevent HIV that only has to be given twice a year, making it a convenient new way to ward off infection in a wide range of people. In two big international studies published last year, the medicine demonstrated a powerful ability to avert HIV infection. With no vaccine on the horizon, the ultra-long acting shot has been hailed by activists as perhaps the best tool the world has so far to wipe out the virus.
Bloomberg11 hours agoHealthBloombergGilead's Twice-a-Year HIV Prevention Shot Wins FDA ApprovalBy Updated on Save Gilead Sciences Inc. said it won US approval for a drug to prevent HIV that only has to be given twice a year, making it a convenient new way to ward off infection in a wide range of people. In two big international studies published last year, the medicine demonstrated a powerful ability to avert HIV infection. With no vaccine on the horizon, the ultra-long acting shot has been hailed by activists as perhaps the best tool the world has so far to wipe out the virus.
11 hours ago
